Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pethidine + dexamethasone is a combination of two pharmaceutical agents used primarily in the perioperative setting, particularly for the prevention and management of postoperative shivering. Pethidine (also known as meperidine) is a synthetic opioid analgesic that acts mainly as an agonist at the mu-opioid receptor, providing both analgesia and anti-shivering effects, likely through direct action on thermoregulatory centers or opioid receptors. Dexamethasone is a potent synthetic glucocorticoid corticosteroid with strong anti-inflammatory and immunosuppressive properties; it reduces shivering by decreasing the core-to-skin temperature gradient via its anti-inflammatory action and inhibition of vasoconstrictors and pyrogenic cytokines. The combination has been shown to be effective in reducing postoperative shivering compared to placebo or either agent alone[1][3][2]. Both drugs are widely used individually for various indications—pethidine for pain relief and shivering control, dexamethasone for inflammation, immune modulation, nausea/vomiting prevention, and other perioperative uses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pethidine + dexamethasone.